Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Journal of Cancer Research and Clinical Oncology
|
January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Satoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
Urology
|
December 18, 2024
Significance of Targeted Antimicrobial Prophylaxis Using Rectal-culture Selective Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial
Takuya Sadahira, Takanori Sekito, Yuki Maruyama, et al.
Journal of Endourology
|
September 3, 2025
Outcome and Impact of Diagnostic Ureteroscopy in Clinically Suspected Upper Urinary Tract Carcinoma <i>in Situ</i>
Satoshi Katayama, Katsumi Sasaki, Norihiro Kusumi, et al.
Journal of Endourology
|
September 12, 2024
Clinical Significance of Tumor Location for Ureteroscopic Tumor Grading in Upper Tract Urothelial Carcinoma
Satoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
World Journal of Urology
|
February 24, 2025
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact
Tatsuo Fukushima, Takuya Tsujino, Moritoshi Sakamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 9, 2022
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy
Satoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
Scientific Reports
|
July 27, 2025
Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy
Tatsushi Kawada, Satoshi Katayama, Takafumi Yanagisawa, et al.
Targeted Oncology
|
November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis
Takafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Urologic Oncology
|
December 21, 2023
Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab
Satoshi Katayama, Takehiro Iwata, Tasushi Kawada, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Journal of Cancer Research and Clinical Oncology
|
January 8, 2022
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
Satoshi Katayama, Victor M Schuettfort, Benjamin Pradere, et al.
Urology
|
December 18, 2024
Significance of Targeted Antimicrobial Prophylaxis Using Rectal-culture Selective Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial
Takuya Sadahira, Takanori Sekito, Yuki Maruyama, et al.
Journal of Endourology
|
September 3, 2025
Outcome and Impact of Diagnostic Ureteroscopy in Clinically Suspected Upper Urinary Tract Carcinoma <i>in Situ</i>
Satoshi Katayama, Katsumi Sasaki, Norihiro Kusumi, et al.
Journal of Endourology
|
September 12, 2024
Clinical Significance of Tumor Location for Ureteroscopic Tumor Grading in Upper Tract Urothelial Carcinoma
Satoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
World Journal of Urology
|
February 24, 2025
Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact
Tatsuo Fukushima, Takuya Tsujino, Moritoshi Sakamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
November 9, 2022
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy
Satoshi Katayama, Benjamin Pradere, Nico C Grossman, et al.
Scientific Reports
|
July 27, 2025
Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy
Tatsushi Kawada, Satoshi Katayama, Takafumi Yanagisawa, et al.
Targeted Oncology
|
November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis
Takafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Urologic Oncology
|
December 21, 2023
Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab
Satoshi Katayama, Takehiro Iwata, Tasushi Kawada, et al.
Page
of 15